Hôpital Necker Enfants Malades — Paris, Île-de-France Region

Public research footprint of Hôpital Necker Enfants Malades, compiled from the ClinicalTrials.gov public registry.

400

Registered studies

129

Active

Recruiting now

213

Completed

Stopped or withdrawn

Most-studied conditions

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative… · Solid Organ Transplant Complications · Allogeneic Hematopoietic Cell Transplant · Stem Cell Transplant Complications

Recently updated registry entries

NCT07319091 — Cystinosis and Mitochondrial Metabolism (Recruiting)
NCT04624230 — Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate… (Active Not Recruiting)
NCT04175600 — A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Necker Enfants Malades?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.